How much does Pharmaceuticals Direct Limited make?

Pharmaceuticals Direct Limited reported revenue of £25.2m and £1.3m profit in the year to 31 Mar 2025, according to its accounts filed at Companies House.

How many employees does Pharmaceuticals Direct Limited have?

Pharmaceuticals Direct Limited reported an average of 26 employees in the year to 31 Mar 2025.

Is Pharmaceuticals Direct Limited profitable?

Yes — Pharmaceuticals Direct Limited reported a profit of £1.3m in the year to 31 Mar 2025.

Company No. 03884028 · Incorporated 25 Nov 1999

Pharmaceuticals Direct Limited

Registered name: PHARMACEUTICALS DIRECT LIMITED

Part of Sip Trustees Limited group

Pharmaceuticals Direct Limited made £25.2m revenue and £1.3m profit in the year to 31 Mar 2025.

Pharmaceuticals Direct Limited’s revenue fell 25% to £25.2m in the year to 31 Mar 2025, with £1.3m profit and 26 employees. The company is classified under “wholesale of pharmaceutical goods”; we hold 4 years of its filed accounts.

Full P&L filedSection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: London
Age: 26 yrs · since 1999
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Mar 2025

Key figures

Revenue

£25.2m

Growth ▼25.1%

Profit

£1.3m

Growth ▲40.7%

Profit margin

5.3%

Gross 19.6%

Employees

Change ▲18.2%

Profit / employee

£51k

Revenue/employee £969k

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2022	31 Mar 2023	31 Mar 2024	31 Mar 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£33.2m	£31.3m	£33.6m	£25.2m
Cost of sales	£27.6m	£25.4m	£28.7m	£20.3m
Gross profit	£5.6m	£5.9m	£4.9m	£4.9m
Operating profit	£1.2m	£2.2m	£1.3m	£1.5m
Profit before tax	£1.1m	£2m	£1.3m	£1.6m
Profit after tax	£924k	£1.6m	£942k	£1.3m
Profit (best available)	£924k	£1.6m	£942k	£1.3m
Staff costs	£1.7m	£1.7m	£1.8m	£1.7m
Employees (average)	24	24	22	26
Ratios
Profit margin	2.8%	5%	2.8%	5.3%
Gross margin	16.9%	18.8%	14.6%	19.6%
Revenue per employee	£1.4m	£1.3m	£1.5m	£969k
Profit per employee	£38.5k	£65.9k	£42.8k	£51k
Growth (year on year)
Revenue growth	—	▼5.5%	▲7.3%	▼25.1%
Profit growth	—	▲71.1%	▼40.4%	▲40.7%
Headcount growth	—	0%	▼8.3%	▲18.2%
Balance sheet — indirect signals, not revenue
Cash at bank	£425k	£218k	£212k	£94.7k
Net assets	£33.1m	£34.7m	£35.6m	£37m
Fixed assets	£16.2m	£16.1m	£16m	£16.1m
Current assets	£33.7m	£34.8m	£32.7m	£33.5m
Debtors	£26.9m	£28m	£27.6m	£26.8m
Deferred income	£109k	£592k	£130k	£415k
Source	Accounts · bulk data Dec 2023	Accounts · bulk data Dec 2023	FullAccounts · bulk data Dec 2024	FullAccounts · bulk data Dec 2025

Derived from the latest filing

How the business works

Profit margin: 5.3%; Profit ÷ revenue.
Gross margin: 19.6%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £969k; Revenue ÷ average employees.
Profit per employee: £51k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 63.9%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 1.7%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 106.4%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲4%; Now £37m
Cash at bank: ▼55%; Now £94.7k
Headcount: ▲18%; Now 26
Deferred income: ▲219%; Now £415k
Fixed assets: ▲0%; Now £16.1m

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Sip Trustees Limitedultimate parent50–75%
Pharmadent Holdings Limited75–100%
Pharmaceuticals Direct Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (4)

Coombe KP LimitedFigures not disclosed
DHB Oral Healthcare LimitedRev. — · Profit £208k
Pharmadent Investments LimitedFigures not disclosed
Pharmadent LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Mar 2025 (profit £1.3m), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.